These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 17148065

  • 1. Release of SpeA from Streptococcus pyogenes after exposure to penicillin: dependency on dose and inhibition by clindamycin.
    Goscinski G, Tano E, Thulin P, Norrby-Teglund A, Sjölin J.
    Scand J Infect Dis; 2006; 38(11-12):983-7. PubMed ID: 17148065
    [Abstract] [Full Text] [Related]

  • 2. Reduced ability of penicillin to eradicate ingested group A streptococci from epithelial cells: clinical and pathogenetic implications.
    Kaplan EL, Chhatwal GS, Rohde M.
    Clin Infect Dis; 2006 Dec 01; 43(11):1398-406. PubMed ID: 17083011
    [Abstract] [Full Text] [Related]

  • 3. Comparative effects of clindamycin and ampicillin on superantigenic activity of Streptococcus pyogenes.
    Sriskandan S, McKee A, Hall L, Cohen J.
    J Antimicrob Chemother; 1997 Aug 01; 40(2):275-7. PubMed ID: 9301995
    [Abstract] [Full Text] [Related]

  • 4. Penicillin and clindamycin differentially inhibit the production of pyrogenic exotoxins A and B by group A streptococci.
    Mascini EM, Jansze M, Schouls LM, Verhoef J, Van Dijk H.
    Int J Antimicrob Agents; 2001 Oct 01; 18(4):395-8. PubMed ID: 11691576
    [Abstract] [Full Text] [Related]

  • 5. Proteomic analysis of a penicillin-tolerant rgg mutant strain of Streptococcus pyogenes.
    Chaussee MA, McDowell EJ, Rieck LD, Callegari EA, Chaussee MS.
    J Antimicrob Chemother; 2006 Oct 01; 58(4):752-9. PubMed ID: 16891633
    [Abstract] [Full Text] [Related]

  • 6. The effects of chemotherapeutics on the species streptococcus in vitro.
    Výmola F, Jedlicková Z.
    J Hyg Epidemiol Microbiol Immunol; 1975 Oct 01; 19(3):383-8. PubMed ID: 1102599
    [Abstract] [Full Text] [Related]

  • 7. Characteristics of Streptococcus pyogenes strains isolated from Chinese children with scarlet fever.
    Liang Y, Shen X, Huang G, Wang C, Shen Y, Yang Y.
    Acta Paediatr; 2008 Dec 01; 97(12):1681-5. PubMed ID: 18691162
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Influences of linezolid, penicillin, and clindamycin, alone and in combination, on streptococcal pyrogenic exotoxin a release.
    Coyle EA, Cha R, Rybak MJ.
    Antimicrob Agents Chemother; 2003 May 01; 47(5):1752-5. PubMed ID: 12709354
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Growth phase-dependent effect of clindamycin on production of exoproteins by Streptococcus pyogenes.
    Sawai J, Hasegawa T, Kamimura T, Okamoto A, Ohmori D, Nosaka N, Yamada K, Torii K, Ohta M.
    Antimicrob Agents Chemother; 2007 Feb 01; 51(2):461-7. PubMed ID: 17101685
    [Abstract] [Full Text] [Related]

  • 15. Pharmacodynamic effects of sub-MICs of benzylpenicillin against Streptococcus pyogenes in a newly developed in vitro kinetic model.
    Löwdin E, Odenholt I, Bengtsson S, Cars O.
    Antimicrob Agents Chemother; 1996 Nov 01; 40(11):2478-82. PubMed ID: 8913449
    [Abstract] [Full Text] [Related]

  • 16. Detection of live and antibiotic-killed bacteria by quantitative real-time PCR of specific fragments of rRNA.
    Aellen S, Que YA, Guignard B, Haenni M, Moreillon P.
    Antimicrob Agents Chemother; 2006 Jun 01; 50(6):1913-20. PubMed ID: 16723545
    [Abstract] [Full Text] [Related]

  • 17. Revisiting the inoculum effect for Streptococcus pyogenes with a hollow fibre infection model.
    Marum D, Manning L, Raby E.
    Eur J Clin Microbiol Infect Dis; 2021 Oct 01; 40(10):2137-2144. PubMed ID: 33948751
    [Abstract] [Full Text] [Related]

  • 18. Propensity to release endotoxin after two repeated doses of cefuroxime in an in vitro kinetic model: higher release after the second dose.
    Goscinski G, Tano E, Löwdin E, Sjölin J.
    J Antimicrob Chemother; 2007 Aug 01; 60(2):328-33. PubMed ID: 17567631
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Intermedilysin release by Streptococcus intermedius: effects of various antibacterial drugs at sub-MIC levels.
    Taylor MB, Oh JH, Kang KL, Chow VT.
    FEMS Microbiol Lett; 2005 Feb 15; 243(2):379-84. PubMed ID: 15686838
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.